Fibrinolysis, antithrombin III, and protein C in neonates during cardiac operations

Journal of Thoracic and Cardiovascular Surgery

Volumn 112, Issue 3, 1996, Pages 665-671

  Petaja, J ^a   Peltola, K ^a   Sairanen, H ^a   Leijala, M ^a   Kekomaki, R ^a   Vahtera, E ^a   Siimes, M A ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN III; BLOOD CLOTTING FACTOR 7; FIBRIN DEGRADATION PRODUCT; PLASMINOGEN ACTIVATOR INHIBITOR; PROTEIN C; PROTHROMBIN; TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; BLOOD CLOTTING; CARDIOPLEGIA; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL FEATURE; CONGENITAL HEART MALFORMATION; FEMALE; FIBRINOLYSIS; HEART SURGERY; HEMOSTASIS; HUMAN; MALE; NEWBORN; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SURGICAL TECHNIQUE; THROMBOCYTE COUNT; VEIN THROMBOSIS;

EID: 0029859678     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5223(96)70050-8     Document Type: Article

References (27)

1. J Boldt C Knothe E Schindler A Welters F Dapper G Hempelmann Thrombomodulin in pediatric cardiac surgery Ann Thorac Surg 57 1994 1584 1589
2. FH Kern NJ Morana JJ Sears PR Hickey Coagulation defects in neonates during cardiopulmonary bypass Ann Thorac Surg 54 1992 541 546
3. RC Woodman LA Harker Bleeding complications associated with cardiopulmonary bypass Blood 76 1990 1680 1697
4. LA Harker TW Malpass HE Branson EA Hessel SJ Slichter Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass: acquired transient platelet dysfunction associated with selective alfa-granule release Blood 56 1980 824 834
5. SO Turner-Gomes M Andrew J Coles GA Trusler WG Williams M Rabinovitch Abnormalities in von Willebrand factor and antithrombln III after cardiopulmonary bypass operations for congenital heart disease J THORAC CARDIOVASC SURG 103 1992 87 97
6. EF Mammen MH Koets BC Washington LW Wolk JM Brown M Burdick Hemostasis changes during cardiopulmonary bypass surgery Semin Thromb Hemost 11 1985 291 292
7. JC Gill AD Wilson J Endres-Brooks RR Montgomery Loss of the largest von Willebrand factor multimers from the plasma of patients with congenital cardiac defects Blood 67 1986 758 761
8. AS Kestin R Valeri SF Khuri J Loscalzo PA Ellis H MacGregor The platelet function defect of cardiopulmonary bypass Blood 82 1993 107 117
9. DM Cosgrove FD Loop BW Lytle CC Gill LR Golding PC Taylor Determinants of blood utilization during myocardial revascularization Ann Thorac Surg 40 1985 380 384
10. RA Moore KW McNicholas H Naidech S Flicker JD Gallagher Clinically silent venous thrombosis following internal and external jugular central venous cannulation in pediatric cardiac patients Anesthesiology 19 1985 536 538
11. J Petäjä U Lundström M Leijala K Peltola MA Siimes Bleeding and use of blood products after heart operations in infants J THORAC CARDIOVASC SURG 109 1995 524 529
12. CS Manno KW Hedberg HC Kim GR Bunin S Nicolson D Jobes Comparison of the hemostatic effects of fresh whole blood, stored whole blood and components after open heart surgery in children Blood 77 1991 930 936
13. M Andrew B Paes M Johnston Development of the hemostatic system in the neonate and young infant Am J Pediatr Hematol Oncol 12 1990 95 104
14. DR Jobes SC Nicolson JM Steven Inhibition and restoration of hemostasis in the young cardiac surgical patient Cardiol Young 3 1993 370 377
15. FB Ploz W Oeveren RH Bartlett CR Wildevuur Blood activation during neonatal extracorporeal life support J THORAC CARDIOVASC SURG 105 1993 823 832
16. W Van Beaumont Evaluation of hemoconcentration from hematocrit measurements J Appl Physiol 32 1972 712 713
17. G Mellbring S Dahlgren B Wiman Plasma fibrinolytic activity in patients undergoing major abdominal surgery Acta Chir Scand 151 1985 109 114
18. J Stibbe C Kluft EJP Brommer M Gomes DS DeJong J Nauta Enhanced fibrinolytic activity during cardiopulmonary bypass in open heart surgery in man is caused by extrinsic (tissue-type) plasminogen activator Eur J Clin Invest 14 1984 375 382
19. D deProst G Barbier-Boehm J Hazebroucq H Ibrahim MC Bielsky U Hvass Desmopressin has no beneficial effect on excessive postoperative bleeding or blood product requirements associated with cardiopulmonary bypass Thromb Haemost 68 1992 106 110
20. TF Slaughter TH LeBleu JM Douglas JB Leslie JK Parker CS Greenberg Characterization of prothrombin activation during cardiac surgery by hemostatic molecular markers Anesthesiology 80 1994 520 526
21. JH Levy JM Bailey Amrinone: pharmacokinetics and pharmacodynamics J Cardiothoracic Anesth 3 Suppl 1989 10 14
22. DA Notterman Inotropic agents: catecholamines, digoxin, amrinone Crit Care Clin 7 1991 583 613
23. MM McDonald ML Johnson CM Rumack BL Koop MA Guggenheim C Babb Role of coagulopathy in newborn intracranial hemorrhage Pediatrics 74 1984 26 31
24. MJ Manco-Johnson Neonatal antithrombin III deficiency Am J Med 87 1989 49 52
25. MJ Manco-Johnson TC Abshire LJ Jacobson RA Marlar Severe neonatal protein C deficiency: prevalence and thrombotic risk J Pediatr 119 1991 793 798
26. M David M Andrew Venous thromboembolic complications in children J Pediatr 123 1993 337 346
27. E Erikson M Ranby E Gyzander B Risberg Determination of plasminogen activator inhibitor in plasman using t-PA and a chromogenic single-point poly-D-lysine stimulated assay Thromb Res 50 1988 91 101